EUVIMEDEUVIMED entdecken
Multizentrische Studie

Examining the Efficacy of Nivolumab for Gastric Cancer Focusing on Using an Inflammation-based Prognostic Score: A Multicenter Retrospective Study

Nobuhiro Nakazawa, Makoto Sohda, Kohei Tateno, Takayoshi Watanabe, Akiharu Kimura, Norimichi Kogure, Hisashi Hosaka, Atsushi Naganuma, Masanori Sekiguchi, Kana Saito, Kyoichi Ogata, Akihiko Sano und 4 weitere

Anticancer Research · 2023

DOI: 10.21873/anticanres.16236 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Anticancer Research, 2023. Verfasst von Nobuhiro Nakazawa und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgical Science, Gunma University Graduate School of Medicine, Maebashi, Japan. Hauptthemen laut MEDLINE: Nivolumab, Stomach Neoplasms, Antineoplastic Agents, Immunological. Die Arbeit wurde bisher 3-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NivolumabStomach NeoplasmsAntineoplastic Agents, ImmunologicalHumansBiomarkersInflammationLymphocytesNeutrophilsPrognosisRetrospective Studies

Stichwörter der Autor:innen

Gastric cancerinflammation-based prognostic score (IBPS)nivolumabprognostic nutritional index

Substanzen

BiomarkersNivolumabAntineoplastic Agents, Immunological

Autor:innen und Institutionen

  • Department of General Surgical Science, Gunma University Graduate School of Medicine, Maebashi, Japan.
  • Department of General Surgical Science, Gunma University Graduate School of Medicine, Maebashi, Japan; msohda@med.gunma-u.ac.jp.
  • Department of Gastroenterology, Gunma Prefectural Cancer Center, Ohta, Japan.
  • Department of Gastroenterology, National Hospital Organization Takasaki General Medical Center, Takasaki, Japan.
  • Department of Gastroenterology, Isesaki Municipal Hospital, Isesaki, Japan.
  • Department of Surgery, Japan Community Healthcare Organization Gunma Central Hospital, Maebashi, Japan.

Zitieren

APA

Nakazawa, N., Sohda, M., Tateno, K., Watanabe, T., Kimura, A., Kogure, N., Hosaka, H., Naganuma, A., Sekiguchi, M., Saito, K., Ogata, K., Sano, A., Sakai, M., Ogawa, H., Shirabe, K., & Saeki, H. (2023). Examining the Efficacy of Nivolumab for Gastric Cancer Focusing on Using an Inflammation-based Prognostic Score: A Multicenter Retrospective Study. Anticancer Research. https://doi.org/10.21873/anticanres.16236

Vancouver

Nakazawa N, Sohda M, Tateno K, Watanabe T, Kimura A, Kogure N, et al. Examining the Efficacy of Nivolumab for Gastric Cancer Focusing on Using an Inflammation-based Prognostic Score: A Multicenter Retrospective Study. Anticancer Research. 2023. doi:10.21873/anticanres.16236

BibTeX
@article{Nakazawa2023,
  author = {Nakazawa, Nobuhiro and Sohda, Makoto and Tateno, Kohei and Watanabe, Takayoshi and Kimura, Akiharu and Kogure, Norimichi and Hosaka, Hisashi and Naganuma, Atsushi and Sekiguchi, Masanori and Saito, Kana and Ogata, Kyoichi and Sano, Akihiko and Sakai, Makoto and Ogawa, Hiroomi and Shirabe, Ken and Saeki, Hiroshi},
  title = {Examining the Efficacy of Nivolumab for Gastric Cancer Focusing on Using an Inflammation-based Prognostic Score: A Multicenter Retrospective Study},
  journal = {Anticancer Research},
  year = {2023},
  doi = {10.21873/anticanres.16236}
}
Kostenlos starten →